Impact of diabetes mellitus on clinical characteristics, management, and in-hospital outcomes in patients with acute myocardial infarction (from the NCDR)

American Journal of Cardiology

Volumn 114, Issue 8, 2014, Pages 1136-1144

  Rousan, Talla A ^a   Pappy, Reji M ^a   Chen, Anita Y ^b   Roe, Matthew T ^b   Saucedo, Jorge F ^c  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^c NORTHSHORE UNIVERSITY HEALTHSYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOGEN RECEPTOR ANTAGONIST; HEMOGLOBIN A1C; GLYCOSYLATED HEMOGLOBIN;

ACUTE HEART INFARCTION; ADULT; AGED; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HEART MUSCLE REPERFUSION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; OBSERVATIONAL STUDY; PRIORITY JOURNAL; RISK ASSESSMENT; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; ANGIOCARDIOGRAPHY; BLOOD; CLINICAL TRIAL; COMPLICATION; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; ELECTROCARDIOGRAPHY; FOLLOW UP; HEART MUSCLE REVASCULARIZATION; HOSPITAL PATIENT; METABOLISM; MIDDLE AGED; MORBIDITY; MULTICENTER STUDY; MYOCARDIAL INFARCTION; RETROSPECTIVE STUDY; RISK FACTOR; SURVIVAL RATE; TRENDS; UNITED STATES;

AGED; CORONARY ANGIOGRAPHY; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEMOGLOBIN A, GLYCOSYLATED; HOSPITAL MORTALITY; HUMANS; INPATIENTS; MALE; MIDDLE AGED; MORBIDITY; MYOCARDIAL INFARCTION; MYOCARDIAL REVASCULARIZATION; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SURVIVAL RATE; UNITED STATES;

EID: 84921719545     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2014.07.031     Document Type: Article

References (30)

1. Malmberg K, Yusuf S, Gerstein HC, Brown J, Zhao F, Hunt D, Piegas L, Calvin J, Keltai M, Budaj A. Impact of diabetes on long-term prognosis in patients with unstable angina and non-Q-wave myocardial infarction: results of the OASIS (Organization to Assess Strategies for Ischemic Syndromes) registry. Circulation 2000;102:1014-1019.
2. Mak KH, Moliterno DJ, Granger CB, Miller DP, White HD, Wilcox RG, Califf RM, Topol EJ. Influence of diabetes mellitus on clinical outcome in the thrombolytic era of acute myocardial infarction. GUSTO-I investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. J Am Coll Cardiol 1997;30:171-179.
3. Franklin K, Goldberg RJ, Spencer F, Klein W, Budaj A, Brieger D, Marre M, Steg PG, Gowda N, Gore JM. Implications of diabetes in patients with acute coronary syndromes. The Global Registry of Acute Coronary Events. Arch Intern Med 2004;164:1457-1463.
4. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2010;33(Suppl 1):S62-S69.
5. Peterson ED, Roe MT, Rumsfeld JS, Shaw RE, Brindis RG, Fonarow GC, Cannon CP. A call to action (Acute Coronary Treatment and Intervention Outcomes Network): a national effort to promote timely clinical feedback and support continuous quality improvement for acute myocardial infarction. Circ Cardiovasc Qual Outcomes 2009;2:491-499.
6. Peterson ED, Roe MT, Chen AY, Fonarow GC, Lytle BL, Cannon CP, Rumsfeld JS. The NCDR ACTION Registry-GWTG: transforming contemporary acute myocardial infarction clinical care. Heart 2010;96:1798-1802.
7. Mathews R, Peterson ED, Chen AY, Wang TY, Chin CT, Fonarow GC, Cannon CP, Rumsfeld JS, Roe MT, Alexander KP. In-hospital major bleeding during ST-elevation and non-ST-elevation myocardial infarction care: derivation and validation of a model from the ACTION Registry(R)-GWTG. Am J Cardiol 2011;107:1136-1143.
8. Zeger SL, Liang KY. Longitudinal data analysis for discrete and continuous outcomes. Biometrics 2010;42:121-130.
9. Chin CT, Chen AY, Wang TY, Alexander KP, Mathews R, Rumsfeld JS, Cannon CP, Fonarow GC, Peterson ED, Roe MT. Risk adjustment for in-hospital mortality of contemporary patients with acute myocardial infarction: the Acute Coronary Treatment and Intervention Outcomes Network (ACTION) Registry-Get with the Guidelines (GWTG) acute myocardial infarction mortality model and risk score. Am Heart J 2011;161:113-122.e2.
10. Bhatt DL, Roe MT, Peterson ED, Li Y, Chen AY, Harrington RA, Greenbaum AB, Berger PB, Cannon CP, Cohen DJ, Gibson CM, Saucedo JF, Kleiman NS, Hochman JS, Boden WE, Brindis RG, Peacock WF, Smith SC Jr, Pollack CV Jr, Gibler WB, Ohman EM. Utilization of early invasive management strategies for high-risk patients with non-ST-segment elevation acute coronary syndromes: results from the crusade quality improvement initiative. JAMA 2004;292:2096-2104.
11. McGuire DK, Emanuelsson H, Granger CB, Magnus Ohman E, Moliterno DJ, White HD, Ardissino D, Box JW, Califf RM, Topol EJ. Influence of diabetes mellitus on clinical outcomes across the spectrum of acute coronary syndromes. Findings from the GUSTO-IIb study. GUSTO IIb Investigators. Eur Heart J 2000;21:1750-1758.
12. Aronson D, Rayfield EJ, Chesebro JH. Mechanisms determining course and outcome of diabetic patients who have had acute myocardial infarction. Ann Intern Med 1997;126:296-306.
13. Takahashi N, Iwasaka T, Sugiura T, Hasegawa T, Tarumi N, Kimura Y, Kurihara S, Onoyama H, Inada M. Left ventricular regional function after acute anterior myocardial infarction in diabetic patients. Diabetes Care 1989;12:630-635.
14. Smooke S, Horwich TB, Fonarow GC. Insulin-treated diabetes is associated with a marked increase in mortality in patients with advanced heart failure. Am Heart J 2005;149:168-174.
15. Beckman JA, Creager MA, Libby P. Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA 2002;287:2570-2581.
16. Roffi M, Chew DP, Mukherjee D, Bhatt DL, White JA, Heeschen C, Hamm CW, Moliterno DJ, Califf RM, White HD, Kleiman NS, Theroux P, Topol EJ. Platelet glycoprotein IIb/IIIa inhibitors reduce mortality in diabetic patients with non-ST-segment-elevation acute coronary syndromes. Circulation 2001;104:2767-2771.
17. Kastrati A, Mehilli J, Neumann FJ, Dotzer F, ten Berg J, Bollwein H, Graf I, Ibrahim M, Pache J, Seyfarth M, Schuhlen H, Dirschinger J, Berger PB, Schomig A. Abciximab in patients with acute coronary syndromes undergoing percutaneous coronary intervention after clopidogrel pretreatment: the ISAR-REACT 2 randomized trial. JAMA 2006;295:1531-1538.
18. De Luca G, Navarese E, Marino P. Risk profile and benefits from GP IIb-IIIa inhibitors among patients with ST-segment elevation myocardial infarction treated with primary angioplasty: a meta-regression analysis of randomized trials. Eur Heart J 2009;30:2705-2713.
19. Yan RT, Yan AT, Tan M, McGuire DK, Leiter L, Fitchett DH, Lauzon C, Lai K, Chow CM, Langer A, Goodman SG. Underuse of evidencebased treatment partly explains the worse clinical outcome in diabetic patients with acute coronary syndromes. Am Heart J 2006;152:676-683.
20. Lee MS, Jurewitz D, Zimmer R, Pessegueiro A, Bhatia R, Currier J, Yeatman L, Tobis JM. Impact of diabetes and acute coronary syndrome on survival in patients treated with drug-eluting stents. Catheter Cardiovasc Interv 2008;72:909-914.
21. McGuire DK, Granger CB. Diabetes and ischemic heart disease. Am Heart J 1999;138:S366-S375.
22. Behar S, Boyko V, Reicher-Reiss H, Goldbourt U. Ten-year survival after acute myocardial infarction: comparison of patients with and without diabetes. SPRINT Study Group. Secondary Prevention Reinfarction Israeli Nifedipine Trial. Am Heart J 1997;133:290-296.
23. Antonio N, Soares F, Lourenco C, Saraiva F, Goncalves F, Monteiro P, Goncalves L, Freitas M, Providencia LA. Impact of previous insulin therapy on the prognosis of diabetic patients with acute coronary syndromes. Arq Bras Endocrinol Metabol 2010;54:612-619.
24. Sinnaeve PR, Steg PG, Fox KA, Van de Werf F, Montalescot G, Granger CB, Knobel E, Anderson FA, Dabbous OH, Avezum A. Association of elevated fasting glucose with increased short-term and 6-month mortality in ST-segment elevation and non-ST-segment elevation acute coronary syndromes: the Global Registry of Acute Coronary Events. Arch Intern Med 2009;169:402-409.
25. Capes SE, Hunt D, Malmberg K, Gerstein HC. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet 2000;355:773-778.
26. Porter A, Assali AR, Zahalka A, Iakobishvili Z, Brosh D, Lev EI, Mager A, Battler A, Kornowski R, Hasdai D. Impaired fasting glucose and outcomes of st-elevation acute coronary syndrome treated with primary percutaneous intervention among patients without previously known diabetes mellitus. Am Heart J 2008;155:284-289.
27. Meyer JH, Womack CR. Glucose tolerance; a comparison of four types of diagnostic tests in 103 control subjects and 26 patients with diabetes. Am J Med Sci 1950;219:161-173.
28. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data Group. Diabetes 1979;28:1039-1057.
29. International Expert Committee. International Expert Committee report on the role of the a1c assay in the diagnosis of diabetes. Diabetes Care 2009;32:1327-1334.
30. Tian L, Wei C, Zhu J, Liu L, Liang Y, Li J, Yang Y. Newly diagnosed and previously known diabetes mellitus and short-term outcomes in patients with acute myocardial infarction. Coron Artery Dis 2013;24:669-675.